IKI. Kutschka

I. Kutschka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


I. Kutschka has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Vakuumtherapie bei sternaler Wundinfektion - Initiale Therapie zur Infektkontrolle und Überbrückung zur plastisch chirurgischen Rekonstruktion

    by I. Kutschka, S. Dziadzka, A. El Essawi, P.-J. Flory, W. Harringer

    Die Vakuumtherapie (V.A.C.®) stellt bei der sternalen Wundinfektion ein gutes Konzept zur initialen Wundversorgung dar und führt zu einer schnellen Infektkontrolle. Die Entscheidung für eine Reosteosynthese oder eine plastisch chirurgische Rekonstruktion kann im weiteren Verlauf getroffen werden. Wir erzielten bei 10 Patienten mit schwerer sternaler Infektion einen vollständigen Wundverschluss mit initialer V.A.C.®-Therapie und späterer operativer Rekonstruktion. Als Fallbericht beschreiben wir den Verlauf einer Patientin mit besonders schwieriger Wundsituation. Bei Zustand nach Ablatio mammae rechts und Radiatio bei Mammakarzinom entwickelte die Patientin nach koronarer Bypassoperation einen sternalen Wundinfekt mit ausgedehnter Knochennekrose. Eine Kombination aus initialer Vakuumtherapie und späterer plastisch chirurgischer Rekonstruktion durch einen M.-latissimus-dorsi-Schwenklappen führte trotz der schwer geschädigten Weichteile des rechten anterioren Thorax zu einer kompletten Wundheilung. Vacuum Assisted Closure (V.A.C.®) is a sound strategy to control severe poststernotomy infection. Secondary re-wiring of the sternal bone or reconstructive surgery may be required later to achieve complete wound closure. Ten patients with severe sternal bone infection underwent initial V.A.C.® therapy and delayed surgery for wound closure. Complete wound healing was achieved in all cases. As a case report we describe a patient with right-sided mastectomy and irradiation for breast cancer, who developed severe poststernotomy infection and sternal bone necrosis following CABG. A combination of V.A.C.® therapy and surgical reconstruction using a pedicled latissimus dorsi musculocutaneous flap led to complete wound closure.


  • Effectiveness of sotalol and magnesium in the prevention of atrial fibrillation following coronary artery bypass surgery

    by A El-Essawi, S Khan, U Carstens, I Kutschka, W Harringer

    Introduction: Despite substantial research in the postoperative prophylaxis and treatment of atrial fibrillation (AF) it remains one of the most frequent complications following cardiac surgery. Relying on the effectiveness of sotalol in the treatment of AF we set out to evaluate its efficacy in association with magnesium in the prophylaxis of AF after coronary artery bypass surgery. Methods: Between October 2003 and October 2004, 100 patients planned for elective on pump coronary artery bypass surgery were randomized into two equal groups. Exclusion criteria included a QT interval longer than 440 ms, creatinine exceeding 2mg/dl, and a previous history of arrhythmias. The group under investigation received both sotalol and magnesium according to the scheme in Tab. 1. The control group received no prophylaxis but remained on their preoperative medication including β-blockers (n=40/50 patients). Results: Statistically no significant differences in terms of age, sex, comorbidities, ejection fraction or preoperative intake of β-blockers existed between both groups. In the prophylaxis group the incidence of postoperative AF was significantly lower with 18% (n=9) as compared to 40% (n=20) in the control group. Conclusion: Our results indicate that the incidence of AF after coronary artery bypass can be effectively reduced by a combination of sotalol and magnesium. Hence a postoperative prophylaxis should not only prove to be cost effective but will also reduce the additional short and long term morbidity caused by AF.


  • A new minimized perfusion circuit with automatic air detection reduces micro air embolism

    by I Kutschka, U Schönrock, A El-Essawi, M Anssar, W Harringer

    Aims: Minimized perfusion circuits (MPC) are criticized for insufficient air elimination. We evaluated a MPC system (ROCsafe®, Terumo, Japan) with new safety features for air detection and elimination. Methods: Deairing capabilities of the ROCsafe®-MPC and an open extracorporeal circulation (ECC) were compared in vitro. The MPC includes a venous bubble trap and an ultrasound air detector controlling a venous occluder and the speed of the centrifugal pump. Both systems were equipped with a CAPIOX SX 18X membrane oxygenator (Terumo, Japan) and a 40µm AV6SV arterial filter (Pall, USA). During a blood flow of 4 l/min we injected 30 cc air in 30 seconds into the venous line of both systems. Injections and measurements were repeated 10 times. Air bubbles were detected during 2 minutes using an ultrasound dual channel bubble counter (Gampt, Germany). Venous measurements were located after the MPC bubble trap and the ECC hard shell reservoir, respectively. Arterial data were obtained after the arterial filters. ECC measurements were performed with reservoir blood levels of 1000 cc. Results: With active deairing venous bubble count (>40µm) was significantly (p250µm were detected in the MPC compared to 887±560 in the ECC. Using 40µm arterial filters, we detected no relevant air after the filter in the MPC system, but serious numbers of micro air bubbles (6518±3026) in the ECC. Conclusions: The ROCsafe®-MPC with automatic safety features provides effective deairing. Air elimination of the new MPC is superior to conventional open ECC systems.

  • Allograft replacement of the aortic root in patients with complicated aortic valve endocarditis

    by A. El-Essawi, M. Anssar, S. Ulrich, I. Kutschka, K. Felten, W. Harringer

    Introduction: Despite substantial improvements in the diagnosis and management of infective endocarditis the choice of the appropriate graft material in presence of native or prosthetic endocarditis is still lacking. We are reporting our experience with allograft aortic root replacement. Methods: Between October 2001 and January 2005 twenty patients (68±8 years) received an aortic root replacement with a cryopreserved aortic allograft for aortic valve endocarditis. A prosthetic aortic valve was involved in 15 patients, the native aortic valve in 4 patients and an aortic homograft in 1 patient. 10 patients had a periannular abscess while 7 had a complete to near complete annuloaortic dehiscence. Results: No intraoperative death. The early postoperative mortality was 10% (2/20) while the in-hospital mortality was 15% (3/20). Causes of death included persistent septic shock (1 patient) and acute heart failure (2 patients). Discharge echocardiography showed no aortic insufficiency in 14 patients and a trivial aortic insufficiency in 3 patients. At follow-up (24.6±11.9 months; 94% complete) there were 2 late deaths, due to myocardial infarction and acute heart failure. The incidence of recurrent endocarditis or reoperation was nil. At 19.9±11.6 months only 1 patient had an aortic insufficiency grade III, 3 AI I–II, the rest had trivial to no aortic insufficiency. Conclusion: Our results indicate that radical debridement of all infected tissue with reconstruction of the ventriculo-aortic continuity using an aortic allograft can be achieved with acceptable mortality and morbidity. The risk of recurrent endocarditis seems to be very low.